BioCatalystWatch
PTNWorkspace / PTN / OverviewCompany library
PALATIN TECHNOLOGIES INC logo

PALATIN TECHNOLOGIES INC

PALATIN TECHNOLOGIES INC (PTN)

Website

Price
Market cap
Next catalyst4Q 2026once-weekly MC4R selective peptide agonist program · Trial initiationCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

BMT/Tadalafil Co-Formulation

Upcoming / outlook

  • Timing and evidence

PL9588

Peptide

MC1R × MC5R

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

PL9588

Peptide

MC1R × MC5R

PreINDP1P2P3FilingApproved
Upcoming / outlook

BMT/Tadalafil Co-Formulation

Upcoming / outlook

  • Timing and evidence

Other pipelines

Oral Small Molecule MC4R Selective Agonist

Small molecule

MC4R

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

PL2001

MC4R

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

MC4R

Vyleesi (bremelanotide)

Peptide

MC4R × MC1R × PDE5

PreINDP1P2P3FilingApproved
PL8331

MC1R × MC5R

PreINDP1P2P3FilingApproved
PL7737

Small molecule

MC4R

PL9655

Melanocortin receptors

PreINDP1P2P3FilingApproved

Partner / License out

Vyleesi (bremelanotide)

Peptide

Melanocortin receptors

PreINDP1P2P3FilingApproved

MCR

Peptide

Melanocortin receptors

PreINDP1P2P3FilingApproved

History / paused

Vyleesi (bremelanotide)

Peptide

Melanocortin receptors; GLP-1/GIP receptors through tirzepatide

PreINDP1P2P3FilingApproved

Melanocortin receptors

PreINDP1P2P3FilingApproved

Peptide

MC1R × MC5R

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

PTN PR & News

PTN SEC archive